DapaToto - Platform Hiburan Resmi No.1 di Indonesia

dapa totoDapagliflozin reduced the risk of kidney failure and prolonged survival in participants with chronic kidney disease with and without type 2 diabetes, includingDapagliflozin snificantly reduced risk of kidney failure and prolonged survival in patients with CKD with or without type 2 diabetes.